SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-18-038980
Filing Date
2018-09-24
Accepted
2018-09-24 17:23:00
Documents
3
Period of Report
2018-11-01
Effectiveness Date
2018-09-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A bp13135x2_def14a.htm DEF 14A 546244
2 bp13135x2_proxycard01.jpg GRAPHIC 1880085
3 bp13135x2_proxycard02.jpg GRAPHIC 966249
  Complete submission text file 0001140361-18-038980.txt   4274027
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38022 | Film No.: 181084211
SIC: 2834 Pharmaceutical Preparations